Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10591817 | Bioorganic & Medicinal Chemistry Letters | 2014 | 5 Pages |
Abstract
A series of TRPA1 antagonists is described having a 4-aryloxy-1H-pyrrolo[3,2-c]pyridine or a 1-aryloxyisoquinoline scaffold. These compounds have high ligand efficiency and favorable physical properties and may thus serve as scaffolds for further optimization.
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Yun-Jin Hu, Miguel St.-Onge, Sébastien Laliberté, Frédéric Vallée, Shujuan Jin, Leanne Bedard, Jean Labrecque, Jeffrey S. Albert,